Home » Topics » BioWorld Science

BioWorld Science
RSS

Discovery of indazole/indole derivatives acting as glucagon receptor antagonists

Sep. 6, 2019

Zika vaccine averts dengue cross-reactive antibody responses

Sep. 6, 2019

Acesion presents data on the selective negative allosteric SK channel modulator AP-30663

Sep. 6, 2019

New AAV gene therapy for mucopolysaccharidosis IVA

Sep. 6, 2019

Bristol-Myers Squibb describes preclinical profile of apelin receptor agonist BMS-986224

Sep. 6, 2019

Phase III CheckMate-548 study does not meet one of its primary endpoints

Sep. 6, 2019

Patient enrollment ongoing in phase I study of Debio-0123

Sep. 6, 2019

FDA grants IND approval for HH-2710

Sep. 6, 2019

Circulating galectin-1 as a predictive biomarker of CAD and MACE in patients with stable angina

Sep. 6, 2019

CAD-1883 demonstrates promising safety in phase I study

Sep. 6, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...